SACERDOTI, DAVID
 Distribuzione geografica
Continente #
NA - Nord America 14.631
EU - Europa 10.414
AS - Asia 1.484
AF - Africa 9
OC - Oceania 8
SA - Sud America 7
Continente sconosciuto - Info sul continente non disponibili 4
Totale 26.557
Nazione #
US - Stati Uniti d'America 14.601
IT - Italia 8.592
CN - Cina 748
SG - Singapore 494
FI - Finlandia 367
DE - Germania 259
FR - Francia 254
SE - Svezia 228
UA - Ucraina 226
GB - Regno Unito 182
VN - Vietnam 152
NL - Olanda 60
CH - Svizzera 43
IN - India 37
IE - Irlanda 28
RO - Romania 27
AL - Albania 20
ES - Italia 20
CA - Canada 19
GR - Grecia 18
TR - Turchia 15
PL - Polonia 14
RU - Federazione Russa 14
CZ - Repubblica Ceca 11
BG - Bulgaria 10
BE - Belgio 9
MX - Messico 9
IR - Iran 6
TH - Thailandia 6
HU - Ungheria 5
JP - Giappone 5
AT - Austria 4
AU - Australia 4
EU - Europa 4
NZ - Nuova Zelanda 4
TW - Taiwan 4
AF - Afghanistan, Repubblica islamica di 3
HK - Hong Kong 3
MD - Moldavia 3
NG - Nigeria 3
NO - Norvegia 3
SI - Slovenia 3
SM - San Marino 3
AE - Emirati Arabi Uniti 2
BR - Brasile 2
CY - Cipro 2
DK - Danimarca 2
HR - Croazia 2
IL - Israele 2
MY - Malesia 2
PE - Perù 2
RS - Serbia 2
TZ - Tanzania 2
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BD - Bangladesh 1
BO - Bolivia 1
BY - Bielorussia 1
CO - Colombia 1
EC - Ecuador 1
IQ - Iraq 1
LT - Lituania 1
LV - Lettonia 1
LY - Libia 1
MA - Marocco 1
PA - Panama 1
PR - Porto Rico 1
RE - Reunion 1
SK - Slovacchia (Repubblica Slovacca) 1
ZA - Sudafrica 1
Totale 26.557
Città #
Fairfield 2.420
Woodbridge 1.527
Houston 1.325
Ann Arbor 1.282
Ashburn 966
Chandler 882
Wilmington 856
Rome 825
Seattle 807
Cambridge 777
Jacksonville 726
Milan 672
Boardman 379
Singapore 379
Princeton 371
Naples 276
San Diego 219
Padova 216
Bologna 206
Turin 188
Medford 179
Nanjing 160
Dong Ket 148
Florence 131
Santa Clara 129
Beijing 126
Helsinki 115
Des Moines 112
Palermo 102
Roxbury 98
Catania 97
Bari 88
Verona 75
Genoa 71
Guangzhou 60
Hebei 53
Parma 50
Nanchang 48
Shenyang 45
Cagliari 44
Norwalk 44
Pescara 42
Trieste 42
Brescia 37
Salerno 36
Perugia 35
Pisa 35
Changsha 34
Messina 34
Venice 33
Jiaxing 32
London 32
Vicenza 29
Monza 28
Modena 27
Reggio Emilia 26
Bergamo 25
Dallas 25
Lucca 25
Redwood City 25
Tianjin 23
Napoli 22
Dublin 21
New York 21
Trento 21
Livorno 20
Pavia 19
Taranto 19
Udine 19
Jinan 17
Montesilvano Marina 17
Rimini 17
Munich 15
Pune 15
Tirana 15
Ancona 14
Bitonto 13
Dearborn 13
Torino 13
Lentini 12
Rende 12
Varese 12
Caserta 11
Falls Church 11
Ferrara 11
Terni 11
Barletta 10
Como 10
Desio 10
Kharkiv 10
Kilburn 10
Kunming 10
Mascalucia 10
Misterbianco 10
Novara 10
Ogden 10
Sesto San Giovanni 10
Yenibosna 10
Aprilia 9
Aversa 9
Totale 18.428
Nome #
Sistema vascolare epatico 8.159
Epatopatie diffuse 808
Quantitative imaging by pixel-based contrast-enhanced ultrasound reveals a linear relationship between synovial vascular perfusion and the recruitment of pathogenic IL-17A-F+IL-23+ CD161+ CD4+ T helper cells in psoriatic arthritis joints 183
11,12-Epoxyeicosatrienoic acid stimulates heme-oxygenase-1 in endothelial cells 181
Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study 166
Characterization of a murine model of cardiorenal syndrome type 1 by high-resolution Doppler sonography 164
Heterotopic Implantation of Decellularized Pulmonary Artery Homografts In A Rodent Model: Technique Description and Preliminary Report 158
Increased myoendothelial gap junctions mediate the enhanced response to epoxyeicosatrienoic acid and acetylcholine in mesenteric arterial vessels of cirrhotic rats. 148
Carotid plaque detection improves the predictve value of CHA2DS2-VASc score in patients with non-valvular atrial fibrilation: The ARAPACIS Study 140
Arteroportal fistulas between the accessory right hepatic, gastroduodenal and superior mesenteric arteries and portal vein: a difficult technical problem to overcome in liver transplantation 138
Portal vein thrombosis relevance on liver cirrhosis: Italian Venous Thrombotic Events Registry 136
Interobserver and inter-equipment variability of echo-Doppler sonographic evaluation of the superior mesenteric artery. 135
Vascular perfusion kinetics by contrast-enhanced ultrasound are related to synovial microvascularity in the joints of psoriatic arthritis. 130
Acute liver rejection: Accuracy and predictive values of Doppler US measurements - Initial experience 130
Increased EETs participate in peripheral endothelial dysfunction of cirrhosis. 129
11,12-EET increases porto-sinusoidal resistance and may play a role in endothelial dysfunction of portal hypertension 123
Differential effects of partial hepatectomy on hepatic and renal heme and cytochrome P450 metabolism 122
Inhibition of Epoxyeicosatrienoic Acid Production in Rats With Cirrhosis Has Beneficial Effects on Portal Hypertension by Reducing Splanchnic Vasodilation 122
Blood flow of experimental liver metastases in rat as evaluated by the locally injected 133-Xenon washout. 118
New abdominal collaterals at ultrasound: A clue of progression of portal hypertension 118
Paraumbilical vein patency in cirrhosis: effects on hepatic hemodynamics evaluated by Doppler sonography. 117
Chronic CO levels has a beneficial effect on vascular relaxation in diabetes 117
Change in portal flow after liver transplantation: effect on hepatic arterial resistance indices and role of spleen size 117
Novel renal arachidonate metabolites 116
Platelet Count Does Not Predict Bleeding in Cirrhotic Patients: Results from the PRO-LIVER Study 116
Effect of somatostatin on liver blood flow and liver metabolic activity in patients with cirrhosis. 115
Arachidonic acid metabolites and endothelial dysfunction of portal hypertension 114
Hemostatic balance in patients with liver cirrhosis: Report of a consensus conference 114
Haeme oxygenase mediates hyporeactivity to phenylephrine in the mesenteric vessels of cirrhotic rats with ascites 112
Identification of 5,6-trans-epoxyeicosatrienoic acid in the phospholipids of red blood cells 111
Role of the heme oxygenases in abnormalities of the mesenteric circulation in cirrhotic rats 109
Thrombosis of the portal venous system 109
Different hemodynamic patterns of alcoholic and viral endstage cirrhosis: analysis of explanted liver weight, degree of fibrosis and splanchnic Doppler parameters 109
Impaired Response To Angiotensin-ii In Type-1 (insulin-dependent) Diabetes-mellitus - Role of Prostaglandins and Sodium-lithium Countertransport Activity 107
Role of HO/CO in the Control of Peripheral Circulation in Humans. 107
Incidence and Recurrence of Portal Vein Thrombosis in Cirrhotic Patients 107
Carbon monoxide-mediated activation of large-conductance calcium-activated potassium channels contributes to mesenteric vasodilatation in cirrhotic rats 105
Alterations in thyroid Doppler arterial resistance indices, volume and hormones in cirrhosis: Relationships with splanchnic haemodynamics 104
Hepatitis C virus reinfection in liver transplant patients: evaluation of liver damage progression with echo-color doppler. 104
Heme oxygenase: the key to renal function regulation. 103
Changes in gene expression of cytochrome P-450 in liver, kidney and aorta of cirrhotic rats. 102
No association between the degree of liver steatosis and early signs of vasculopathy in T2DM. 102
Hepatitis C Virus Reinfection in Liver Transplant Patients: Evaluation of Liver Damage Progression with Echo-Color Doppler 102
Renal effects of nadolol in cirrhosis. 101
Effect of Potassium Canrenoate, an Anti-aldosterone Agent, on Incidence of Ascites and Variceal Progression in Cirrhosis 101
Clinical and biochemical determinants of the extent of liver steatosis in type 2 diabetes mellitus 101
Molecular Mechanisms Leading to Splanchnic Vasodilation in Liver Cirrhosis 101
Effects of chronic therapy with nadolol on portal hemodynamics and on splanchnic impedance indices using Doppler sonography: Comparison between acute and chronic effects 100
HO-1 Induction Improves The Type-1 Cardiorenal Syndrome in Mice With Impaired Angiotensin II-Induced Lymphocyte Activation. 100
Rat mesenteric arterial dilator response to 11,12-epoxyeicosatrienoic acid is mediated by activating heme oxygenase 100
Eicosanoid-dependent mechanisms in liver disease 99
Clinical role of non-invasive assessment of portal hypertension 99
Accuracy and predictive value of echo-Doppler measurements in acute liver rejection -- initial experience 98
Renal, metabolic and hormonal responses to ingestion of animal and vegetable proteins. 97
Atrogin-1 deficiency promotes cardiomyopathy and premature death via impaired autophagy. 97
Myocardial overexpression of ANKRD1 causes sinus venosus defects and progressive diastolic dysfunction 97
Renal haemodynamics in essential hypertension assessed by 133-Xenon washout and selective renal angiography 96
Vascular disorders of the liver: recommendations from the Italian Association for the Study of the Liver (AISF) ad hoc committee. 95
Carbon monoxide-mediated activation of a large-conductance calcium-activated potassium channels contrinutes to mesenteric vasodilation in cirrhotic rats. 321 : 187-194. 94
Prevalence of Peripheral Artery Disease by Abnormal Ankle-Brachial Index in Atrial Fibrillation: Implications for Risk and Therapy. 94
Beyond scoring: a modern histological assessment of chronic hepatitis should include tissue angiogenesis. 94
Effects of isosorbide dinitrate on portal hypertension in alcoholic cirrhosis. 93
Nadolol for prevention of variceal rebleeding in cirrhosis: a controlled clinical trial. 92
Long-term effects of beta-adrenergic blockade with nadolol on hepatic and renal haemodynamics and function in cirrhotics. 92
Mesenteric arteries responsiveness to acute variations of wall shear stress is impaired in rats with liver cirrhosis. 92
Carbon monoxide-mediated activation of large-conductance calcium-activated potassium channels contributes to mesenteric vasodilatation in cirrhotic rats with ascites 91
Interobserver and inter-equipment variability of echo-Doppler evaluation of the superior mesenteric artery. 90
Splenic impedance indices: a useful method to monitor patients after liver transplantation? 90
Long-term results of a clinical trial of nadolol with or without isosorbide mononitrate for primary prophylaxis of variceal bleeding in cirrhosis. 90
Heme oxygenase regulates the response of intrarenal arteries to alpha-adrenergic stimulation in experimental cirrhosis. 90
Chronic treatment with tin normalizes blood pressure in spontaneously hypertensive rats 89
Gemfibrozil improves insulin sensitivity and flow-mediated vasodilatation in type 2 diabetic patients 89
Role of cytochrome P450-dependent arachidonic acid metabolites in liver physiology and pathophysiology 89
Impaired renal response to a meat meal in insulin-dependent diabetes: role of glucagon and prostaglandins. 89
Heme Oxygenase (HO) mediates hyporeactivity to phenylephrine (PE) in mesenteric vessels of experimental cirrhosis with ascites 89
Hemodynamic and clinical evaluation of nadolol in the treatment of portal hypertension in patients with cirrhosis. 86
Renal cytochrome P450-dependent metabolism of arachidonic acid (AA) in spontaneously hypertensive rats (SHR). 85
Optimizing the time-frame for the definition of bleeding-related death after acute variceal bleeding in cirrhosis 85
Updating prognosis of cirrhosis by Cox's regression model using Child-Pugh score and aminopyrine breath test as time-dependent covariates 85
Nitric oxide modulation of renal and cardiac hemodynamics in type 2 diabetes 84
Effect of a dietary integration with BCAA or casein on nutritional state and lower limb amino acid exchange in cirrhosis 84
Clinical significance of the evaluation of hepatic reticuloendothelial removal capacity in patients with cirrhosis. 83
A CO-releaseng molecule, CORM-3, attenuates ischemia/reperfusion incurie in a new model in pig liver. 81
Prognostic indicators of risk for first variceal bleeding in cirrhosis: A multicenter study in 711 patients to validate and improve the North Italian Endoscopic Club (NIEC) Index 81
The hemodynamic response to medical treatment of portal hypertension as a predictor of clinical effectiveness in the primary prophylaxis of variceal bleeding in cirrhosis 80
Effect of nadolol on liver haemodynamics and function in patients with cirrhosis. 80
Treatment with tin prevents the development of hypertension in spontaneously hypertensive rats. 79
Splenic Doppler impedance indices: influence of different portal hemodynamic conditions. 79
Medication prescription and adherence disparities in non valvular atrial fibrillation patients: an Italian portrait from the ARAPACIS study 79
Carbon monoxide signaling in promoting angiogenesis in human microvessel endothelial cells 79
PGE2 urinary escretion and renal haemodynamics after nadolol treatment of portal hypertension in patients with liver cirrhosis. 78
A Pig Model of Hemivascular Liver Occlusion for The Study of Ischemia-Reperfusion Injury: Use of an Infrared System for Detecting Ischemic Areas 78
Covert hepatic encephalopathy: Agreement and predictive validity of different indices 78
Role of Atrial-natriuretic-peptide In the Pathogenesis of Sodium Retention In Iddm With and Without Glomerular Hyperfiltration 78
Hemodynamic and clinical evaluation of nadolol in the treatment of portal hypertension in patients with cirrhosis. 77
Effects of defibrotide on renal function and urinary prostanoid excretion in ciclosporin-treated rats. 77
Renal effects of nadolol in patients with liver cirrhosis. 77
Noninvasive grading of the severity of portal hypertension in cirrhotic patients by echo-color-Doppler 77
Central Nervous system alterations in liver cirrhosis: the role of portal-systemic shunt and portal hypoperfusion. 18 (1), 51-62 76
The course of galactose elimination capacity in patients with alcoholic cirrhosis: possible use as a surrogate marker for death. 76
Totale 19.058
Categoria #
all - tutte 72.556
article - articoli 53.423
book - libri 554
conference - conferenze 0
curatela - curatele 0
other - altro 158
patent - brevetti 0
selected - selezionate 0
volume - volumi 12.211
Totale 138.902


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.774 0 0 0 0 384 309 360 445 397 365 270 244
2020/20213.657 176 246 170 243 221 290 281 365 450 446 393 376
2021/20223.550 155 437 385 251 192 235 200 344 224 106 330 691
2022/20233.959 573 246 142 302 483 428 350 437 410 145 245 198
2023/20243.982 219 247 261 225 289 210 329 457 199 367 518 661
2024/20252.801 385 477 619 561 759 0 0 0 0 0 0 0
Totale 26.752